On August 23rd, LATS President Gabriela Brenta spoke about the impact of hypothyroidism on patients with thyroid cancer (CDT) during the 1st Argentine Symposium on Thyroid Cancer. The meeting brought together great names of endocrinology in Argentina and worldwide, such as the Markus Luster of Germany, who gave lectures on Therapy with Radioiodo for the CDT current position; Risk Factors in CDT new evidence; Use of dosimetry in CDT; and CDT advanced current management radioresistant and unresectable observation and suppression of TSH, ITK and Future Therapies.
The lectures involved new treatments and recent diagnostic technologies among other subjects.
